(Press-News.org) The use of androgen suppression therapy (AST) in prostate cancer for low-risk cases declined following a decrease in physician reimbursement, according to a study published online TK in The Journal of the National Cancer Institute. However, the indicated use of AST for metastatic disease in the palliative setting did not decline in the same period.
The use of AST in prostate cancer increased more than threefold between 1991 and 1999 both for patients with metastatic cancer and those with low-risk disease, but AST treatment in the latter group has not been shown to improve survival. The Medicare Modernization Act, passed in 2003, reduced reimbursements for AST by 64% between 2004 and 2005, but the effect on prescribed treatments is unknown.
To determine whether this bill reduced usage of AST in both patients with metastatic disease and those with low-risk disease, Sean P. Elliott, M.D., of the University of Minnesota, and colleagues, conducted an observational study of a cohort of men in the U.S. with prostate cancer. The cohort, which was identified by the Surveillance, Epidemiology and End Results (SEER) database, included 72,818 men, 64,788 of whom had low-risk disease, and 8,030 with metastatic disease.
The researchers found that for men with metastatic disease, there was no statistically significant change in AST usage between 2004 and 2005. For men with low-risk prostate cancer, for whom AST is not a generally accepted indication, usage of AST fell by 40 percent.
The authors controlled for various factors that could account for these findings, apart from reimbursement, including a trend toward using longer-acting agents, intermittent AST use, or growing awareness of side effects associated with AST. However, they conclude that the decline "likely represents a real effect of reimbursement change and not physician awareness of clinical evidence." Furthermore, they do not suggest that financial incentives led to increased AST use in the 1990s. "Our analysis only allows us to conclude that the reduction in reimbursement is associated with a decline in use in 2004-2005," they write.
In an accompanying editorial, Nancy L. Keating, M.D., of Brigham and Women's Hospital and Harvard Medical School, writes that although the effect of the Medicare Modernization Act on non-prostate cancers needs further study, this study's findings "provide reassurance that, at least for prostate cancer patients, the Medicare Modernization Act is not promoting over-use or negatively influencing access to recommended care of GnRH agonist therapy, and it may actually be leading to more appropriate care."
INFORMATION:
Contact:
Article: Justin Paquette, Media Relations Manager, University of Minnesota, jpaquett@mnu.edu
Editorial: David Cameron, Communications Officer, 617-432-0441 david_cameron@hms.harvard.edu
Decreased physician reimbursement for hormone therapy may reduce over-treatment of prostate cancer
2010-12-04
ELSE PRESS RELEASES FROM THIS DATE:
Assessing positive outcomes of phase III trials
2010-12-04
Randomized phase III studies should be designed to find out whether a new drug or treatment makes a meaningful difference in patients' survival or quality of life, according to a commentary published online December 3rd in The Journal of the National Cancer Institute. Instead, most trials now are designed to detect a statistically significant difference between treatment and control groups, which may not be clinically meaningful, write Alberto Ocana, M.D., Ph.D. and Ian F. Tannock, M.D., Ph.D., of Princess Margaret Hospital in Toronto.
Regulatory agencies such as the ...
Improvement needed for mastectomy outcome reporting
2010-12-04
Improved standards for outcome reporting in breast reconstruction are needed, according to a review published online December 3rd in The Journal of the National Cancer Institute.
Every year in the United States up to 40% of women with breast cancer undergo a mastectomy. They say the most valuable factor in their decision-making is information from health professionals. However, that information is largely dependent on the quality, reporting, and interpretation of research data on surgical procedures.
To summarize the reporting standards of surgical outcomes in breast ...
Breast CT imaging system marches forward as pain-free tool to aid mammograms
2010-12-04
While questions persist about the best ways to detect breast cancer early, a CT imaging system developed at the University of Rochester Medical Center and first unveiled five years ago is in a better position today to enter the fray -- at least in a supporting role to conventional mammography.
URMC radiologist Avice O'Connell, M.D., was invited to summarize the studies conducted thus far on the Cone Beam Computed Tomography (CBCT) scanner, at the Radiological Society of North America Annual Scientific Assembly in Chicago at 8:30 a.m. (EST) on Friday, December 3, 2010.
O'Connell ...
Anesthetic gases heats climate as much as 1 million cars
2010-12-04
When doctors want their patients asleep during surgery they gently turn the gas tap. But Anaesthetic gasses have a global warming potential as high as a refrigerant that is on its way to being banned in the EU. Yet there is no obligation to report anaesthetic gasses along with other greenhouse gasses such as CO2, refrigerants and laughing gas.
One kilo of anaesthetic gas affects the climate as much as 1620 kilos of CO2. That has been shown by a recent study carried out by chemists from University of Copenhagen and NASA in collaboration with anaesthesiologists from the ...
Dynamics of chaperone protein critical in rescuing brains of Alzheimer's mice from neuron damage
2010-12-04
Tampa, FL (Dec. 3, 2010) -- Dynamic regulation of the chaperone protein Hsp27 was required to get rid of abnormally accumulating tau in the brains of mice genetically modified to develop the memory-choking tau tangles associated with Alzheimer's disease, a University of South Florida-led study found.
Researchers at the USF Health Byrd Alzheimer's Institute demonstrated that the effective switching of Hsp27 between its active and deactivated states was critical on two fronts -- to promote the recycling of the tau protein in healthy nerve cells and to clear abnormal tau ...
Data mining depression
2010-12-04
Could information technology and data mining techniques be used to improve the diagnosis and treatment of depression? That's the question scientists in Australia hope to have answered in a forthcoming issue of the International Journal of Functional Informatics and Personalised Medicine.
Maja Hadzic, Fedja Hadzic and Tharam Dillon of the Digital Ecosystems and Business Intelligence Institute, at Curtin University of Technology, in Perth, explain how depression is rapidly emerging as one of the major health problems now facing society. They add that the World Health Organization ...
Polymeric porous framework of a bismuth citrate-based complex: A potential vehicle for drug delivery
2010-12-04
YANG Nan, MAO ZongWan and SUN HongZhe et al., at the Department of Chemistry, University of Hong Kong and Sun Yat-sen University have characterized a series of bismuth citrate complexes by X-ray crystallography and modeled the structure of ranitidine bismuth citrate, a medicine used widely for the treatment of peptic ulcer and gastric reflux disease. The polymeric framework of bismuth citrate may serve as a "drug carrier" for delivery of other drugs in the human body. This significant contribution is reported in SCIENCE CHINA Chemistry 2010, 53(10).
Elements that possess ...
Faulty gene linked to disorders of sexual development
2010-12-04
Scientists have discovered that the alteration of a single gene could cause some male embryos to develop as females.
The breakthrough will improve diagnosis and clinical management of patients with disorders of sex development (DSD). These conditions occur when the testis or ovary does not develop properly in the embryo, causing genital abnormalities in one in 4500 babies.
An international team including researchers from the Murdoch Childrens Research Institute and the University of Melbourne identified the gene alteration in a group of patients including two families ...
Your Web surfing history is accessible (without your permission) via JavaScript
2010-12-04
The Web surfing history saved in your Web browser can be accessed without your permission. JavaScript code deployed by real websites and online advertising providers use browser vulnerabilities to determine which sites you have and have not visited, according to new research from computer scientists at the University of California, San Diego.
The researchers documented JavaScript code secretly collecting browsing histories of Web users through "history sniffing" and sending that information across the network. While history sniffing and its potential implications for ...
Graptolite fauna indicates the beginning of the Kwangsian Orogeny
2010-12-04
Our research at the State Key Laboratory of Palaeobiology and Stratigraphy, Nanjing Institute of Geology and Palaeontology, has shown, based on a refined division and correlation of the graptolite-bearing strata in southern Jiangxi, China, that the Kwangsian Orogeny commenced in the early Katian Age of the Late Ordovician. Because of its significant research value, this study is published in Issue 11 of Science China Earth Sciences.
An angular unconformity separating the Lower-Middle Devonian and underlying strata is widespread in the Zhujiang region of South China, and ...